SOUTH SAN FRANCISCO, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ:CBIO) (the “Company”) today announced the closing of an underwritten public offering of 8,700,000 shares of its common stock, offered at a price of $5.7… […]
The US political system is struggling with historic challenges, says former UC President Janet Napolitano […]
LEHI, Utah & SAN FRANCISCO–(BUSINESS WIRE)–Ancestry®, the global leader in family history and consumer genomics, today announced the appointment of Mark Thompson as chairman of the board. Thompson formerly served as President & CEO at The New… […]
Gift from Heising-Simons Family Fund supports five-year, $1 million grants to researchers in the physical sciences […]
PLEASANTON, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) — 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2020 after market close on Wednesday, February 17, 2021. The com… […]
Michael Yang
→ The winds of change are freshening off the coast in San Diego for stem cell biotech ViaCyte, which has appointed Michael Yang as president and CEO. Yang replaces Paul Laikind, who retired as ViaCyte’s CEO in September after eight years a… […]
A new study finds emissions from deforestation, conversion of wild landscapes to agriculture, and other changes in land use worldwide contributed 25 percent of all human-caused emissions between 2001 and 2017. Expanding agricultural production in Latin… […]
IRVINE, Calif.–(BUSINESS WIRE)—- $SWKS #5G–Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog semiconductors connecting people, places and things, today announced that its board of directors has authorized the repurcha… […]
It only took 20 years, but Jude Samulski is finally turning AskBio into a gene therapy behemoth in the hills of North Carolina.
The now Bayer-owned biotech announced Friday they were bringing over the clinical team from Brain Neurotherapy Bio, completi… […]
MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Easte… […]
Copyright © 2021 Biotech Networks, LLC
